Laura N Eadie

10PUBLICATIONS
19CO-AUTHORS
Haematological tumoursBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2025
T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments.

Maxim Buckley, David T Yeung, Deborah L White

|Jun 07, 2024
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Laura N Eadie, Elias Lagonik, Elyse C Page

|Oct 14, 2023
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.

Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley

|Jul 31, 2023
Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.

Laura N Eadie, Jacqueline A Rehn, Caitlin E Schutz

|Feb 25, 2023
Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Laura N Eadie, Jacqueline A Rehn, James Breen

|Oct 17, 2022
RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).

Jacqueline Rehn, Chelsea Mayoh, Susan L Heatley

Pageof 2

Frequent Collaborators

7 joint publications

Deborah L White

5 joint publications

Susan L Heatley

4 joint publications

Barbara J McClure

3 joint publications

David T Yeung